Your browser is no longer supported. Please, upgrade your browser.
We’ve released a new Beta version of our Futures section! Try it now. We look forward to your feedback! ×
Settings
INSY [NASD]
INSYS Therapeutics, Inc.
Index- P/E58.44 EPS (ttm)1.04 Insider Own0.80% Shs Outstand35.46M Perf Week4.85%
Market Cap2.16B Forward P/E22.54 EPS next Y2.70 Insider Trans-46.84% Shs Float11.21M Perf Month2.60%
Income38.00M PEG2.09 EPS next Q0.40 Inst Own40.60% Short Float56.48% Perf Quarter31.76%
Sales222.10M P/S9.70 EPS this Y-26.20% Inst Trans1.11% Short Ratio16.72 Perf Half Y63.04%
Book/sh4.73 P/B12.85 EPS next Y59.30% ROA22.50% Target Price62.50 Perf Year65.34%
Cash/sh2.34 P/C26.00 EPS next 5Y28.00% ROE28.70% 52W Range20.52 - 62.48 Perf YTD44.17%
Dividend- P/FCF78.66 EPS past 5Y17.30% ROI22.80% 52W High-2.72% Beta1.36
Dividend %- Quick Ratio2.50 Sales past 5Y- Gross Margin89.80% 52W Low196.20% ATR2.39
Employees382 Current Ratio3.30 Sales Q/Q65.40% Oper. Margin28.80% RSI (14)61.35 Volatility3.20% 4.18%
OptionableYes Debt/Eq0.00 EPS Q/Q-59.70% Profit Margin17.10% Rel Volume0.71 Prev Close60.99
ShortableYes LT Debt/Eq0.00 EarningsMar 03 BMO Payout0.00% Avg Volume378.65K Price60.78
Recom1.80 SMA205.71% SMA507.73% SMA20044.73% Volume269,735 Change-0.34%
Mar-09-15Reiterated RBC Capital Mkts Outperform $65 → $71
Mar-04-15Reiterated RBC Capital Mkts Outperform $57 → $65
Dec-15-14Reiterated RBC Capital Mkts Outperform $53 → $57
Nov-12-14Reiterated RBC Capital Mkts Outperform $51 → $53
Nov-12-14Downgrade Oppenheimer Outperform → Perform $40
Oct-02-14Initiated RBC Capital Mkts Outperform $51
Aug-14-13Reiterated Oppenheimer Outperform $23 → $27
Jul-31-13Initiated Oppenheimer Outperform $23
Apr-13-15 12:25PM  Breakfast Of Champions: Is Pot Good For You?
Apr-08-15 11:42AM  Pfizer, Eli Lilly Were The Original Medical Marijuana Sellers at Forbes +9.92%
Apr-01-15 07:26PM  Lightning Round: Be careful-this lurks everywhere at CNBC
07:00PM  Cramer Remix: It's time to buy these oil stocks at CNBC
08:55AM  Marijuana Bill Gains Momentum In Congress
Mar-20-15 01:06PM  Cannabis companies: puffed up at Financial Times
Mar-19-15 03:12PM  The Marijuana CARERS Act: What You Need To Know
Mar-16-15 10:12AM  Marijuana: What A Difference Two Decades Makes
Mar-12-15 11:28AM  Marijuana Remains The 'Wild West' Of Investing
Mar-11-15 01:04PM  INSYS THERAPEUTICS, INC. Financials
Mar-09-15 12:15PM  Marijuana Investment: Is It Time?
Mar-03-15 05:14PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or Princ
11:46AM  Insys Therapeutics Q4 Beat Drives Short-Lived Rally at Investor's Business Daily
08:51AM  INSYS Therapeutics Slumps: INSY Falls 7% in Session - Tale of the Tape
08:19AM  Insys Therapeutics tops 4Q revenue forecasts
07:25AM  Insys Therapeutics Reports Fourth Quarter and Year End 2014 Results at noodls
07:25AM  Insys Therapeutics Announces Its Pharmaceutical Cannabidiol Received Fast Track Designation From FDA for the Treatment of Dravet Syndrome at noodls
07:07AM  Q4 2014 Insys Therapeutics Inc Earnings Release - Before Market Open
07:00AM  Insys Therapeutics Reports Fourth Quarter and Year End 2014 Results Marketwired
06:00AM  Retail earnings, auto sales big for traders at CNBC
Mar-02-15 04:01PM  The Shuman Law Firm Investigates INSYS Therapeutics, Inc. Business Wire -6.96%
Feb-26-15 09:56AM  Medivation Tops Q4 Views On Strong Xtandi Results at Investor's Business Daily +5.67%
07:00AM  Insys Therapeutics Announces Its Pharmaceutical Cannabidiol Received Fast Track Designation From FDA for the Treatment of Dravet Syndrome Marketwired
Feb-25-15 07:56PM  The hot health care stocks to buy now for your 401(K) Fox Business Video
Feb-24-15 10:04AM  United Therapeutics Blood Pressure Drug Lifts Q4 at Investor's Business Daily
07:00AM  Insys Therapeutics In-Licenses Novel Mast Cell Therapy for Chronic Pelvic Pain Marketwired
Feb-17-15 04:30PM  Insys Therapeutics to Report Fourth Quarter and Year-End 2014 Results Marketwired
Feb-04-15 09:10AM  Earth Science Tech Building A Nutrition Empire Based On High Grade CBD and Nutraceutical Retailing Accesswire
Jan-26-15 08:00AM  Insys Therapeutics Receives FDA Orphan Drug Designation for Its Liposomal Encapsulated Paclitaxel for the Treatment of Ovarian Cancer Marketwired
Jan-23-15 08:54AM  Will Insys Therapeutics (INSY) Continue to Surge Higher? - Tale of the Tape Zacks
07:28AM  The Marijuana Market Is Expanding: Here Are A Couple Ways To Get Involved Benzinga
Jan-12-15 07:00AM  Insys Therapeutics to Initiate Five Phase III Clinical Trials in 2015 Marketwired +6.14%
Dec-30-14 09:53AM  Novus MedPlan Progress Exceeds Expectations, Company Poised For Banner 2015 Accesswire
Dec-18-14 02:52PM  Stocks Hold Near Session Highs; FedEx Bounces Back at Investor's Business Daily +8.25%
Dec-08-14 10:11AM  Novus Becomes an Insurance Leader as MMJ Market Approaches Tipping Point Accesswire
Dec-02-14 11:59AM  A Drug Maker Uses Doctors With Troubled Pasts to Promote a Painkiller at The Wall Street Journal
Nov-25-14 09:40AM  Insys' Cannabidiol Gets another Orphan Drug Designation Zacks
Nov-24-14 07:23AM  Cardica (CRDC) in Focus: Stock Moves Up 8.7% in Session Zacks
Nov-21-14 10:30AM  Insider Trading Alert - INSY, LNKD And IMPV Traded By Insiders at TheStreet
Nov-19-14 04:30PM  Insys Therapeutics to Present at 26th Annual Piper Jaffray Healthcare Conference Marketwired
Nov-17-14 05:42AM  Weakness Seen in Vascular Solutions (VASC): Stock Plunges 22.2% Zacks
Nov-15-14 06:33AM  The most dangerous medical marijuana myth at USA TODAY
Nov-14-14 06:05AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
Nov-12-14 10:00AM  Insys Therapeutics (INSY) Is Weak On High Volume Today at TheStreet
07:43AM  Insys Therapeutics downgraded by Oppenheimer Briefing.com
06:07AM  INSYS THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report EDGAR Online
05:27AM  INSYS Therapeutics (INSY) in Focus: Stock Rises 12% Zacks
Nov-11-14 06:02PM  Nasdaq stocks posting largest percentage increases AP +12.03%
04:16PM  Dow, S&P 500 close at record on Veterans Day at CNBC
11:33AM  Insys Q3 Beats Estimates, Helping Stock Rebound at Investor's Business Daily
11:04AM  Insys Therapeutics (INSY) Stock Soars Today on Third Quarter Earnings Beat at TheStreet
08:17AM  US stock futures add to gains; D.R. Horton reports at CNBC
08:11AM  Insys Therapeutics posts 3Q profit AP
07:07AM  Q3 2014 Insys Therapeutics Inc Earnings Release - Before Market Open CCBN
Nov-10-14 05:16PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financi EDGAR Online
Oct-31-14 04:08PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi EDGAR Online
Oct-22-14 05:01PM  Biotechs Show Fed Chief's Not Much Of A Stock Analyst at Investor's Business Daily
Oct-16-14 06:01AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
Oct-15-14 05:46PM  [$$] FDA Rejects Insys's Dronabinol Application at The Wall Street Journal +6.54%
Oct-06-14 09:00AM  Neutra Corp Doubles but Cannabis Stocks Move Largely Lower Last Week Accesswire -7.05%
Oct-02-14 12:03PM  Insys Therapeutics Up On Bullish Analyst Initiation at Investor's Business Daily +6.93%
Sep-18-14 09:55AM  Cannabis Technologies Looks to Diversify Pipeline with New Hire Accesswire
Sep-12-14 05:11PM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Other Events EDGAR Online
Sep-03-14 08:00AM  Insys Therapeutics, Inc. Named Arizona Bioscience Company of the Year Business Wire
Aug-26-14 03:30PM  Insys Therapeutics' Cannabidiol Gets Orphan Drug Status Zacks
Aug-25-14 10:17AM  FDA names potential Insys treatment an orphan drug AP
Aug-22-14 09:45AM  Novus Aims to Make Medical Cannabis Affordable Accesswire
Aug-19-14 06:30AM  5 Stocks Jumping on Unusual Volume at TheStreet
Aug-18-14 06:05AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Material Modification to Rig EDGAR Online +5.81%
Aug-14-14 06:04AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
Aug-12-14 10:53AM  Stocks Stake Out Thin Gains; Intercept, Insys, Autohome Gain at Investor's Business Daily
10:01AM  INSYS THERAPEUTICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and EDGAR Online
09:07AM  Stock Futures Hem And Haw; Intercept Pharmaceuticals Soars at Investor's Business Daily
07:07AM  Q2 2014 Insys Therapeutics Inc Earnings Release - Before Market Open CCBN
Aug-11-14 02:33PM  Cannabis Should Be Treated as an Agricultural Commodity, Not a Biotech Investment Accesswire +7.64%
Aug-08-14 04:45PM  GW Pharma, Insys Face Off In Cannabis Drug Space at Investor's Business Daily
Jul-16-14 03:40PM  6 stocks to watch at MarketWatch
Jul-11-14 06:34PM  MONDAY DEADLINE: Levi & Korsinsky, LLP Notifies Investors of Class Action Against INSYS Therapeutics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of July 14, 2014 -- INSY PR Newswire
05:02PM  Is This Marijuana Stock GW Pharmaceuticals' Biggest Risk? at Motley Fool
04:17PM  SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against INSYS Therapeutics, Inc. and Certain Officers - INSY Marketwired
Jul-10-14 10:00PM  INSYS 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Securities Class Action Lawsuit Against INSYS Therapeutics, Inc. - INSY Marketwired
01:58PM  UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against INSYS Therapeutics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of July 14, 2014 Business Wire
Jul-09-14 04:10PM  Insys Completes Study on Dronabinol Oral Solution Zacks
03:55PM  Faruqi & Faruqi, LLP Reminds Investors in INSYS Therapeutics, Inc. (INSY) of Imminent Deadline to Protect Your Rights GlobeNewswire
Jul-08-14 11:36AM  INSYS Therapeutics Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor Investigate Possible Breaches of Fiduciary Duty by Officers and Directors Business Wire -5.20%
07:00AM  Insys Therapeutics Updates Timing of NDA for Dronabinol Oral Solution Marketwired
Jul-07-14 06:51PM  EQUITY ALERT: Rosen Law Firm Reminds INSYS Therapeutics Investors of Important July 2014 Class Action Deadline -- INSY Marketwired
05:42PM  UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against INSYS Therapeutics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of July 14, 2014 -- INSY Marketwired
Jul-04-14 01:17PM  Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In INSYS Therapeutics, Inc. (INSY) To Contact The Firm PR Newswire
Jul-03-14 10:30AM  Insys Therapeutics' Epilepsy Therapy Gains FDA Orphan Drug Status Zacks
Jul-02-14 04:15PM  UPCOMING DEADLINE: LEVI & KORSINSKY, LLP Notifies Investors of Class Action Against INSYS Therapeutics, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of July 14, 2014 -- INSY GlobeNewswire
07:00AM  Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Dravet Syndrome, a Rare Form of Epilepsy Marketwired
Jul-01-14 10:32AM  INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against INSYS Therapeutics, Inc. Business Wire
04:00AM  SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in INSYS Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline -- INSY GlobeNewswire
Jun-30-14 01:34PM  DEADLINE ALERT: Rigrodsky & Long, P.A. Reminds Shareholder Of INSYS Therapeutics, Inc. Of Upcoming Deadline Business Wire
10:58AM  GW Pharma Drug Impresses At Epilepsy Conference at Investor's Business Daily
07:00AM  Insys Therapeutics Reaffirms Second Quarter 2014 Revenue Guidance Marketwired
Jun-25-14 09:12AM  Wednesday's Top Health Care Stories: Aerie, Insys, and Owens & Minor at Motley Fool +6.51%
08:14AM  [$$] Insys: Cannibas-Based Epilepsy Treatment Gets Orphan Drug Status at The Wall Street Journal
07:00AM  Insys Therapeutics Receives FDA Orphan Drug Designation for Its Pharmaceutical Cannabidiol as a Potential Treatment for Rare Form of Epilepsy, Lennox-Gastaut Syndrome Marketwired
Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets Subsys, a proprietary sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant cancer patients; and Dronabinol SG Capsule, a dronabinol soft gelatin capsule that is generic equivalent to Marinol, an approved second-line treatment for chemotherapy-induced nausea and vomiting, and anorexia associated with weight loss in patients with AIDS. Its products candidates also include Dronabinol Oral Solution, a proprietary orally administered liquid formulation of dronabinol. The company is headquartered in Chandler, Arizona.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Babich Michael LPresident and CEOMar 20Option Exercise3.255,00016,250207,752Mar 20 04:43 PM
Babich Michael LPresident and CEOMar 17Option Exercise7.2627,400198,924230,152Mar 18 04:49 PM
Babich Michael LPresident and CEOMar 17Sale57.7527,4001,582,441202,752Mar 18 04:49 PM
Babich Michael LPresident and CEOMar 16Option Exercise2.8277,600218,877250,352Mar 18 04:49 PM
Babich Michael LPresident and CEOMar 16Sale59.1347,6002,814,473202,752Mar 18 04:49 PM
FOURTEAU PATRICKDirectorMar 11Sale59.9410,000599,35970,000Mar 12 10:36 AM
STANLEY THEODORE HDirectorMar 10Option Exercise7.263,30023,9584,300Mar 10 04:47 PM
STANLEY THEODORE HDirectorMar 10Sale60.033,300198,0861,000Mar 10 04:47 PM
STANLEY THEODORE HDirectorMar 05Option Exercise7.266,70048,6427,700Mar 06 08:03 PM
STANLEY THEODORE HDirectorMar 05Sale60.116,700402,7461,000Mar 06 08:03 PM
BAKER DARRYL SChief Financial OfficerFeb 09Option Exercise7.268,75263,54028,129Feb 10 04:30 PM
BAKER DARRYL SChief Financial OfficerFeb 09Sale52.188,752456,71419,377Feb 10 04:30 PM
BAKER DARRYL SChief Financial OfficerFeb 06Option Exercise3.8021,24880,76040,625Feb 10 04:30 PM
BAKER DARRYL SChief Financial OfficerFeb 06Sale52.2521,2481,110,25019,377Feb 10 04:30 PM
Babich Michael LPresident and CEODec 19Option Exercise3.252,5008,125172,295Dec 22 04:42 PM
FOURTEAU PATRICKDirectorNov 19Sale39.1125,000977,67380,000Nov 20 05:43 PM
Babich Michael LPresident and CEONov 04Option Exercise2.367,50017,700177,295Nov 04 07:02 PM
Babich Michael LPresident and CEONov 04Sale37.277,500279,504169,795Nov 04 07:02 PM
Babich Michael LPresident and CEONov 03Option Exercise2.3672,500171,100242,295Nov 04 07:02 PM
Babich Michael LPresident and CEONov 03Sale38.8072,5002,813,223169,795Nov 04 07:02 PM
Babich Michael LPresident and CEOOct 21Option Exercise3.5420,00070,800189,795Oct 22 04:50 PM
Babich Michael LPresident and CEOOct 21Sale40.1720,000803,404169,795Oct 22 04:50 PM
Babich Michael LPresident and CEOOct 16Option Exercise3.255,00016,250165,562Oct 16 05:34 PM
STANLEY THEODORE HDirectorAug 13Buy33.933,000101,8005,100Aug 15 12:51 PM
KAPOOR JOHN NDirectorJun 16Buy26.135,000130,62621,174,805Jun 18 10:39 AM
KAPOOR JOHN NDirectorJun 13Buy25.445,000127,20521,169,805Jun 17 12:23 PM
KAPOOR JOHN NDirectorJun 12Buy24.8420,000496,76221,164,805Jun 16 12:57 PM
KAPOOR JOHN NDirectorJun 11Buy24.5420,000490,80021,144,805Jun 13 12:39 PM
KAPOOR JOHN NDirectorMay 19Option Exercise9.2915,991148,48215,991May 20 06:38 PM
STANLEY THEODORE HDirectorMay 19Buy24.831,00024,8306,100May 19 03:22 PM
BAKER DARRYL SChief Financial OfficerMay 15Option Exercise7.2610,00072,60014,687May 16 02:12 PM
Babich Michael LPresident and CEOMay 15Option Exercise3.257,50024,375150,562May 16 02:09 PM
FOURTEAU PATRICKDirectorMay 15Buy22.777,500170,775105,000May 15 07:42 PM
MEYER STEVEN JDirectorMay 15Buy21.385,000106,9005,000May 15 07:39 PM
STANLEY THEODORE HDirectorMay 15Buy20.983,00062,9405,100May 19 03:22 PM